Welcome to our dedicated page for Essity news (Ticker: ETTYF), a resource for investors and traders seeking the latest updates and insights on Essity stock.
Essity Aktiebolag (ETTYF) is a hygiene and health company in the sanitary paper product manufacturing industry that regularly publishes news on corporate governance, financial reporting, sustainability initiatives and strategic transactions. Its press releases and reports cover developments across professional hygiene, consumer tissue, medical solutions and advanced wound care, giving investors and observers insight into how the business evolves over time.
News from Essity often centers on financial results and reporting, including interim reports where the company discusses net sales, organic growth, margins, cash flow and the impact of external factors such as raw material costs and market conditions. These announcements are typically accompanied by webcasts and teleconferences where executives present the results and answer questions, and they may also be broadcast on platforms such as LinkedIn.
Another important category of Essity news involves Annual General Meetings and shareholder decisions. AGM releases describe approvals of financial statements, dividend resolutions, remuneration for board and committee members, elections of board members and the Chairman of the Board, appointment of auditors, and authorizations for share buy-backs or changes to the articles of association and share capital. These updates provide context on Essity’s governance and capital structure.
Essity also issues news about strategic and sustainability initiatives, such as collaborations to recycle paper cup waste into Tork branded toilet paper in Germany, expansion of reusable product offerings, and programs to optimize manufacturing and reduce exposure to wood-based fresh-fiber pulp. Announcements about acquisitions, distribution agreements and price increases in Consumer Tissue and other product categories further illustrate how Essity responds to market dynamics. For anyone tracking ETTYF, this news feed offers a consolidated view of Essity’s operational, financial and sustainability-related developments.
Essity (OTC:ETTYF) has completed the acquisition of Edgewell Personal Care's feminine care business for USD 340m (approx. SEK 3bn) on a cash- and debt-free basis, effective February 2, 2026. The deal includes Carefree, Stayfree and o.b. in North America and global Playtex feminine care rights.
The asset purchase covers a portfolio of liners, pads and tampons across the US, Canada and the Caribbean and a production facility in Dover, Delaware. Operations will be consolidated into Essity accounts as of the closing date.
Essity (ETTYF) held its 2025 Annual General Meeting at Stockholm Waterfront Congress Centre. The company approved a dividend of SEK 8.25 per share for FY2024, payable on April 3, 2025. The meeting approved new board remuneration rates, with directors receiving SEK 960,000 and the Chairman SEK 2,880,000, plus additional compensation for committee roles.
Shareholders approved a cash-based incentive program and the Board's remuneration report. The meeting elected two new directors, Alexander Lacik and Katarina Martinson, while re-electing eight existing members. Jan Gurander was elected Chairman. Ernst & Young AB was appointed as auditor until 2026. The meeting also authorized share buybacks of Essity B shares and approved amendments to the articles of association.
Essity (ETTYF) announced that President and CEO Magnus Groth will step down from his position during 2025 after serving 14 years with the Group, including almost ten years as CEO. The Board has initiated an immediate recruitment process for his successor.
Under Groth's leadership since 2015, first at SCA and then at Essity, the company has achieved significant growth in profitability, innovation, and global expansion. Chairman Jan Gurander acknowledged Groth's important role in establishing Essity's platform for continued profitable growth.
Groth, who has a one-year notice period, will continue in his role until a successor is appointed. During his tenure, Essity has developed into a world-leading hygiene and health company with strong brands, market positions, and recognized sustainability work.
Essity will release its Q2 2024 interim report on July 18 at approximately 07:00 CET. The report will be presented by President and CEO Magnus Groth and CFO Fredrik Rystedt during a live webcast and teleconference at 09:00 CET the same day.
The webcast and teleconference can be accessed via a provided link and will be available for later viewing. Contact numbers for the conference call are provided for participants from the UK, USA, and Sweden. The presentation will also be broadcast live on LinkedIn.
For more information, contact Vice Presidents Per Lorentz and Sandra Åberg. Further details and downloadable files are available on Cision and Essity's news page.
Summary not available.
Essity, in collaboration with McDonald's, is launching a recycling project in Germany to convert used paper cups into Tork branded toilet paper. Initiated in 2020, the project aims to recycle approximately 1,200 tons of waste annually. This collaboration will not only reduce McDonald's waste and carbon footprint but also align with Essity's sustainability goals. The solution extends Essity's Tork PaperCircle® service, enhancing its circular economy initiatives.
Essity reported a net sales decline of 18.3% to SEK 27,528m for Q1 2021, primarily due to the COVID-19 pandemic and stockpiling effects from the previous year. Organic net sales fell 9.9%, with e-commerce increasing 14%. Operating profit (EBITA) dropped 31% to SEK 3,664m. Despite challenges, market shares rose in several sectors, and the company announced acquisitions to boost growth, including a USD 1,540m deal for control of Productos Familia S.A.. Future price increases are planned to counteract higher raw material costs.
Essity, a hygiene and health company, announced price increases in Consumer Tissue products due to rising raw material costs. The hikes are expected to average in the mid-to-high single digits in key markets. Additionally, the company is preparing for price adjustments in other product categories affected by similar cost pressures. This announcement is in compliance with the EU Market Abuse Regulation, signaling a proactive response to inflationary trends impacting production costs.
Essity has announced price increases in its Consumer Tissue category due to rising raw material costs, effective in key markets. The average increase is in the mid-to-high single digits. Additionally, the company is planning price hikes in other product categories affected by these costs. This decision aligns with their commitment to maintaining profitability amidst challenging market conditions.
Essity has acquired the distribution rights to Sorbact® wound care technology in Australia and New Zealand from Bayport Brands. In 2020, Sorbact® sales in this region reached AUD 1.7 million (approx. SEK 11 million). This acquisition is part of Essity's strategy to enhance its presence in the advanced wound care market, where it has shown promising sales growth. Sorbact® is known for its innovative approach in wound treatment, effectively binding bacteria and fungi while being non-toxic. Essity acquired 75% of Abigo Medical, the manufacturer of Sorbact®, in February 2020.